Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area

Affiliations

• ¹ European Centre for Disease Prevention and Control, Stockholm, Sweden.
• ² Dept of Infectious Diseases, Karolinska Institute, Stockholm, Sweden.
• ³ Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
• ⁴ Dept of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
• ⁵ Norwegian Institute of Public Health, Oslo, Norway.
• ⁶ TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, UK.
• ⁷ Dept of Infectious Disease Epidemiology, London School of Hygiene, London, UK.
• ⁸ Pallas Health Research and Consultancy, Rotterdam, The Netherlands.
• ⁹ TB Alert, Brighton, UK.
• ¹⁰ University Dept of Infectious and Tropical Diseases, and WHO Collaborating Centre for TB/HIV Collaborative Activities and for the TB Elimination Strategy, University of Brescia, Brescia, Italy.
• ¹¹ Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.
• ¹² National Institute for TB, Lung Disease and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia.
• ¹³ Dept of Respiratory Medicine, 1st Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.
• ¹⁴ Dept of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
• ¹⁵ KNCV Tuberculosis Foundation, The Hague, The Netherlands.
• ¹⁶ National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
• ¹⁷ Public Health England, London, UK.